Chetan Puttagunta
CIK 1695859 · last filed 2026-10-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMPL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESTC | Director | 15,912 | $101.23 | $1.61M | -$17.5K | 9 | 2026-10-19 |
| Confluent, Inc. (CFLT) Delisted | 10%+ Owner | 150,771 | $30.99 | $4.67M | -$8.73M | 3 | 2022-08-12 |
| AMPL | Director | 52,051 | $17.48 | $910.1K | -$416.16M | 2 | 2022-08-12 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 1,759,659 | $15.00 | $26.39M | $404.1K | 1 | 2018-06-28 |
Recent Filings · Page 2 of 2
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-26 | Confluent, Inc. (CFLT) Delisted | Sell (S) | −31,926 | -$2.40M | EDGAR |
| 2021-10-05 | ESTC | Grant (A) | +1,323 | $0 | EDGAR |
| 2021-09-30 | AMPL | Mixed | −8,260,384 | -$415.98M | EDGAR |
| 2021-04-01 | ESTC | Buy (P) | +5,000 | $558.1K | EDGAR |
| 2020-10-22 | ESTC | Grant (A) | +1,487 | $0 | EDGAR |
| 2018-06-28 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +192,425 | $404.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.